Ruconest

Product manufactured by Santarus, Inc.

Application Nr Approved Date Route Status External Links
BLA125495 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ruconest Is A C1 Esterase Inhibitor [Recombinant] Indicated For The Treatment Of Acute Attacks In Adult And Adolescent Patients With Hereditary Angioedema (Hae). Limitation Of Use: Effectiveness Was Not Established In Hae Patients With Laryngeal Attacks. Ruconest Is A C1 Esterase Inhibitor [Recombinant] Indicated For The Treatment Of Acute Attacks In Adult And Adolescent Patients With Hereditary Angioedema (Hae). ( 1 ) Limitation Of Use: Effectiveness Was Not Established In Hae Patients With Laryngeal Attacks.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Conestat Alfa

Comments